|

EVAXION BIOTECH A/S (EVAX)

US29970R1059 - ADR

0.7921  -0.02 (-2.21%)

After market: 0.79 0 (-0.27%)

EVAXION BIOTECH A/S

NASDAQ:EVAX (11/28/2023, 7:00:44 PM)

After market: 0.79 0 (-0.27%)

0.7921

-0.02 (-2.21%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)11-14 2023-11-14/amc
Earnings (Next)04-25 2024-04-25/amc
Ins OwnersN/A
Inst Owners0.61%
Market Cap22.08M
Shares27.87M
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts85
IPO02-05 2021-02-05
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

EVAX Daily chart

Company Profile

Evaxion Biotech A/S engages in the discovery and development of immunotherapies for cancer and infectious diseases. The firm decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.

Company Info

EVAXION BIOTECH A/S

Bredgade 34E, Copenhagen K

COPENHAGEN 1260

CEO: Lars Staal Webner

Employees: 63

Website: https://www.evaxion-biotech.com/

EVAX News

News Imagea day ago - Evaxion BiotechEvaxion to Unveil Potentially Groundbreaking AI-Immunology™ Precision Cancer Vaccine Concept
News Imagea day ago - Evaxion BiotechEvaxion to Unveil Potentially Groundbreaking AI-Immunology™ Precision Cancer Vaccine Concept

Proof of Concept – Evaxion’s AI-Immunology™ platform demonstrates success in designing precision cancer vaccines in hematological cancers by targeting a...

News Image13 days ago - Evaxion BiotechEvaxion présente la preuve de concept de son modèle unique d’IA prédisant les réponses à l’immunothérapie du cancer

Evaxion présente aujourd’hui un nouveau modèle d’IA conçu pour prédire les réponses des patients à une immunothérapie anticancéreuse standard.Le modèle a...

News Image13 days ago - Evaxion BiotechEvaxion präsentiert Proof-of-Principle für sein einzigartiges KI-Modell zur Vorhersage des Ansprechens auf Krebsimmuntherapie

Evaxion präsentiert heute ein neuartiges KI-Modell zur Vorhersage des Ansprechens von Patienten auf eine Standard-KrebsimmuntherapieDas Modell zeigt ein...

News Image14 days ago - Evaxion BiotechEvaxion Presents Proof-of-Principle for Its Unique AI Model Predicting Responses to Cancer Immunotherapy
News Image14 days ago - Evaxion BiotechEvaxion Presents Proof-of-Principle for Its Unique AI Model Predicting Responses to Cancer Immunotherapy

Evaxion today presents a novel AI model designed to predict patient responses to standard-of-care cancer immunotherapyThe model demonstrates promising...

EVAX Twits

Here you can normally see the latest stock twits on EVAX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example